Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
|Videos|September 11, 2016
How Close Are We to Finding a Cure for HIV?
Author(s)Contagion Editorial Staff
David Rosenthal, DO, PhD, medical director for the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwell Health, discusses how close researchers are to finding a cure for HIV.
Advertisement
David Rosenthal, DO, PhD, medical director for the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwell Health, discusses how close researchers are to finding a cure for HIV.
Interview Transcript (slightly modified for readability)
“[The National Institute of Health (NIH) has] been increasing the funding and decreasing the funding for many, many years, and so, [when it comes to the question of] how close it is? I don’t know. I believe in the work that Anthony Fauci is doing and I think that the NIH is certainly getting much closer than we were. I think that 2015 was a very good year for HIV cure and HIV prevention in ways we haven’t seen in previous years due to several new breakthroughs in clinical trials.
I’m not a soothsayer; I can’t tell you exactly when it’s going to happen. I think that we’re getting closer than we were, but just like we’ve been working for many, many years for diseases like cancer, and finding a cure for cancer, a vaccine for cancer, we haven’t been fully effective in doing that for many cancers. We still aren’t quite there yet for HIV; I think we have some work still to do, so I’m not expecting something to happen in the coming year but I also don’t think that it’s going to be 50 years from now when we’re going to have some answers.”
Advertisement
Related to this article
Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Advertisement
Advertisement